Advertisement
Screener

WEST PHARMACEUTICAL SERVICES, INC. (WST) EBITDA

WEST PHARMACEUTICAL SERVICES, INC. (WST) EBITDA

  • 2026-06-30: Basis Reported; EBITDA $225.3M; Operating income (m); Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA $222.3M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA $203.6M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA $210.6M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2010-12-31 to 2026-06-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$225.3M(m)(m)(m)25.83%$43.20M*$124.00M*$543.10M$19.70M$117.60M$32.20M
2026-03-31Reported$222.3M(m)(m)(m)26.31%$42.70M$89.90M$548.50M$15.80M$99.50M$44.70M
2025-12-31Reported$203.6M(m)(m)(m)25.29%(m)(m)(m)(m)(m)(m)
2025-09-30Reported$210.6M(m)(m)(m)26.17%$63.30M*$197.20M*$510.30M$17.10M$102.70M$34.00M
2025-06-30Reported$195.1M(m)(m)(m)25.45%$75.20M*$177.10M*$492.60M$19.10M$95.90M$30.20M
2025-03-31Reported$147M(m)(m)(m)21.06%$71.30M$129.40M$466.10M$16.30M$88.00M$24.10M
2024-12-31Reported$200.3M(m)(m)(m)26.75%(m)(m)(m)(m)(m)(m)
2024-09-30Reported$201.5M(m)(m)(m)26.98%$81.30M*$180.10M*$482.20M$15.50M$83.50M$32.40M
2024-06-30Reported$165.1M(m)(m)(m)23.52%$100.20M*$165.00M*$472.10M$17.50M$83.00M$21.90M
2024-03-31Reported$158.4M(m)(m)(m)22.78%$90.60M$118.20M$465.20M$17.60M$86.70M$16.40M
2023-09-30Reported(m)$177.30M(m)$747.40M(m)$95.80M*$230.10M*$459.10M$16.40M$89.00M$29.40M
2023-06-30Reported(m)$182.50M(m)$753.80M(m)$75.40M*$169.20M*$462.40M$16.50M$88.40M$34.80M
2023-03-31Reported(m)$155.30M(m)$716.60M(m)$82.10M$138.10M$445.30M$17.10M$86.00M$23.60M
2022-09-30Reported(m)$186.20M(m)$686.90M(m)$57.80M*$168.90M*$418.90M$13.60M$66.30M$20.40M
2022-06-30Reported(m)$228.40M(m)$771.30M(m)$66.10M*$173.10M*$449.80M$14.40M$81.50M$44.20M
2022-03-31Reported(m)$189.70M(m)$720.00M(m)$65.80M$151.20M$435.40M$14.60M$83.40M$21.20M
2021-09-30Reported(m)$181.40M(m)$706.50M(m)$65.30M*$190.10M*$418.30M$13.10M$91.90M$12.00M
2021-06-30Reported(m)$211.30M(m)$723.60M(m)$56.90M*$144.40M*$408.50M$13.80M$92.70M$32.30M
2021-03-31Reported(m)$175.60M(m)$670.70M(m)$54.70M$88.70M$398.80M$12.20M$80.20M$28.70M
2020-09-30Reported(m)$99.20M(m)$548.00M(m)$47.50M*$118.60M*$353.40M$12.50M$76.20M$21.10M
2020-06-30Reported(m)$103.60M(m)$527.20M(m)$37.10M*$148.10M*$332.10M$10.80M$77.70M$16.00M
2020-03-31Reported(m)$88.00M(m)$491.50M(m)$32.10M$57.10M$324.50M$10.70M$71.80M$15.00M
2019-09-30Reported(m)$67.30M(m)$456.10M(m)$31.70M*$108.10M*$308.30M$9.30M$64.80M$10.90M
2019-06-30Reported(m)$80.50M(m)$469.70M(m)$28.30M*$105.10M*$311.80M$9.60M$70.30M$15.50M
2019-03-31Reported(m)$70.70M(m)$443.50M(m)$28.80M$47.60M$296.70M$9.80M$68.60M$16.10M
2018-09-30Reported(m)$60.80M(m)(m)(m)$26.50M*$88.40M*$296.10M$10.10M$64.90M$8.00M
2018-06-30Reported(m)$60.30M(m)(m)(m)$20.20M*$82.00M*$305.30M$10.80M$70.00M$6.00M
2018-03-31Reported(m)$53.40M(m)(m)(m)$28.00M$45.00M$281.30M$9.60M$68.30M$12.50M
2017-09-30Reported(m)$62.90M(m)(m)(m)$34.30M*$75.80M*$273.10M$9.10M$62.60M$14.00M
2017-06-30Reported(m)$42.00M(m)(m)(m)$29.50M*$85.30M*$272.60M$10.00M$61.30M$2.90M
2017-03-31Reported(m)$60.50M(m)(m)(m)$37.50M$20.70M$253.50M$10.30M$62.50M$2.20M
2016-09-30Reported(m)$51.30M(m)(m)(m)$48.70M*$68.40M*$255.60M$9.00M$58.30M$14.40M
2016-06-30Reported(m)$61.20M(m)(m)(m)$35.00M*$76.20M*$254.70M$8.80M$62.50M$17.00M
2016-03-31Reported(m)$30.00M(m)(m)(m)$39.00M$3.00M$238.80M$9.40M$58.10M$6.90M
2015-09-30Reported(m)-$3.50M(m)(m)(m)$29.70M*$68.80M*$236.20M$8.50M$54.60M-$6.60M
2015-06-30Reported(m)$39.10M(m)(m)(m)$26.70M*$77.50M*$241.50M$8.10M$60.80M$9.20M
2015-03-31Reported(m)$47.80M(m)(m)(m)$30.40M-$1.90M$226.20M$7.50M$55.20M$12.50M
2014-09-30Reported(m)$44.00M(m)(m)(m)$28.60M*$63.90M*$246.00M$9.60M$56.00M$11.70M
2014-06-30Reported(m)$54.10M(m)(m)(m)$24.50M*$64.20M*$247.10M$9.90M$57.50M$14.00M
2014-03-31Reported(m)$39.30M(m)(m)(m)$31.70M$8.80M$240.40M$10.00M$56.40M$9.80M
2013-09-30Reported(m)$39.70M(m)(m)(m)$29.30M*$53.30M*$236.30M$9.60M$56.10M$10.60M
2013-06-30Reported(m)$42.50M(m)(m)(m)$22.10M*$79.50M*$233.60M$9.50M$59.70M$10.30M
2013-03-31Reported(m)$43.30M(m)(m)(m)$61.70M$18.90M$227.70M$9.10M$59.10M$8.60M
2012-09-30Reported(m)$26.30M(m)(m)(m)$29.00M*$51.60M*$213.40M$8.20M$53.70M$9.00M
2012-06-30Reported(m)$35.60M(m)(m)(m)$37.00M*$52.20M*$226.10M$8.20M$54.40M$6.50M
2012-03-31Reported(m)$41.70M(m)(m)(m)$32.40M$13.80M$215.20M$8.30M$51.30M$9.80M
2011-09-30Reported(m)$26.10M(m)(m)(m)$24.20M*$39.70M*$212.20M$7.70M$45.70M$6.60M
2011-06-30Reported(m)$27.80M(m)(m)(m)$18.40M*$39.70M*$223.30M$7.30M$46.40M$5.30M
2011-03-31Reported(m)$28.80M(m)(m)(m)$19.40M$9.50M$207.40M$6.90M$50.60M$6.10M
2010-09-30Reported(m)$25.30M(m)(m)(m)$17.20M*$48.00M*$196.70M$5.90M$44.90M$4.50M
2010-06-30Reported(m)$30.50M(m)(m)(m)$14.90M*$31.60M*$198.60M$5.70M$45.80M$6.60M
2010-03-31Reported(m)$28.90M(m)(m)(m)$17.70M$11.50M$192.50M$5.40M$46.60M$6.20M
2009-09-30Reported(m)$25.90M(m)(m)(m)$27.60M*$39.00M*$187.20M$5.10M$44.30M$6.00M
2009-06-30Reported(m)$28.70M(m)(m)(m)(m)(m)$182.30M$4.70M$45.10M$6.10M

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported$756.3M(m)(m)(m)24.60%$285.90M$754.80M$1.97B$74.30M$393.60M$121.60M
2024-12-31Reported$725.3M(m)(m)(m)25.07%$377.00M$653.40M$1.89B$69.10M$338.50M$107.50M
2023-12-31Reported$813.3M(m)(m)(m)27.57%$362.00M$776.50M$1.82B$68.40M$353.40M$122.30M
2022-12-31Reported$854.6M(m)(m)(m)29.60%$284.60M$724.00M$1.75B$58.50M$316.90M$114.70M
2021-12-31Reported$874.6M(m)(m)(m)30.89%$253.40M$584.00M$1.66B$52.80M$362.80M$107.20M
2020-12-31Reported$516M(m)(m)(m)24.03%$174.40M$472.50M$1.38B$46.90M$302.00M$72.50M
2019-12-31Reported$400M(m)(m)(m)21.74%$126.40M$367.20M$1.23B$38.90M$272.70M$59.00M
2018-12-31Reported$344.7M(m)(m)(m)20.07%$104.70M$288.60M$1.17B$40.30M$262.90M$41.40M
2017-12-31Reported$322.5M(m)(m)(m)20.17%$130.80M$263.30M$1.09B$39.10M$246.00M$80.90M
2016-12-31Reported$285.9M(m)(m)(m)18.95%$170.20M$219.40M$1.01B$36.80M$239.60M$54.40M
2015-12-31Reported$218.5M(m)(m)(m)15.61%$131.60M$212.40M$944.00M$34.10M$233.00M$26.30M
2014-12-31Reported$272M(m)(m)(m)19.14%$111.90M$182.90M$973.60M$37.30M$228.70M$47.20M
2013-12-31Reported$247.6M(m)(m)(m)18.09%$151.90M$220.50M$933.70M$37.90M$234.90M$40.20M
2012-12-31Reported$212M(m)(m)(m)16.74%$131.30M$187.40M$878.70M$33.20M$218.10M$32.70M
2011-12-31Reported$185.3M(m)(m)(m)15.54%$95.40M$130.70M$853.00M$29.10M$191.10M$23.50M
2010-12-31Reported$163.9M(m)(m)(m)14.84%$71.10M$138.30M$786.60M$23.90M$187.70M$13.60M
2009-12-31Reported$165.60M*$97.50M$68.10M(m)(m)$104.90M$137.70M$752.10M$19.90M$177.70M$13.50M
2008-12-31Reported(m)$124.10M(m)(m)(m)$138.60M$135.00M$748.50M$18.70M$159.30M$23.70M

Similar stocks

Stock NameCountryMarket CapPE Ratio
DEXCOM INC (DXCM)United States$33.004B25.42
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44